×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CCCC – c4 therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CCCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
07:16 am
cccc
Targeted Protein Degradation Industry Forecast to Reach $4.37 Billion by 2034: PROTACs Lead the Charge with Promising Innovations in Oncology [Yahoo! Finance]
Low
Report
Targeted Protein Degradation Industry Forecast to Reach $4.37 Billion by 2034: PROTACs Lead the Charge with Promising Innovations in Oncology [Yahoo! Finance]
12/19
07:42 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $8.00.
Low
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $12.00 price target on the stock, up previously from $8.00.
12/8
12:30 pm
cccc
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
Low
Report
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
11/21
04:18 am
cccc
Comprehensive Synovial Sarcoma Pipeline Landscape Report for 2024: In-depth Analysis of 20+ Pipeline Drugs and 15+ Companies [Yahoo! Finance]
Low
Report
Comprehensive Synovial Sarcoma Pipeline Landscape Report for 2024: In-depth Analysis of 20+ Pipeline Drugs and 15+ Companies [Yahoo! Finance]
11/20
07:07 am
cccc
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors [Yahoo! Finance]
Medium
Report
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors [Yahoo! Finance]
11/20
07:00 am
cccc
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
Medium
Report
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
11/18
08:50 am
cccc
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
Medium
Report
C4 Therapeutics, Inc. (NASDAQ: CCCC) is now covered by analysts at Stephens. They set an "equal weight" rating and a $4.00 price target on the stock.
11/6
07:00 am
cccc
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
Medium
Report
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/9
09:50 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Dec 09
Medium
Report
Form 8-K C4 Therapeutics, Inc. For: Dec 09
11/21
04:17 pm
cccc
Form 4 C4 Therapeutics, Inc. For: Nov 19 Filed by: Hoerter Steven L.
Medium
Report
Form 4 C4 Therapeutics, Inc. For: Nov 19 Filed by: Hoerter Steven L.
11/21
04:16 pm
cccc
Form 3 C4 Therapeutics, Inc. For: Nov 19 Filed by: Hoerter Steven L.
Medium
Report
Form 3 C4 Therapeutics, Inc. For: Nov 19 Filed by: Hoerter Steven L.
11/20
07:12 am
cccc
Form 8-K C4 Therapeutics, Inc. For: Nov 20
Medium
Report
Form 8-K C4 Therapeutics, Inc. For: Nov 20
11/18
04:43 pm
cccc
Form 144 C4 Therapeutics, Inc. Filed by: Salter Malcolm
Low
Report
Form 144 C4 Therapeutics, Inc. Filed by: Salter Malcolm
11/15
04:06 pm
cccc
Form 424B3 C4 Therapeutics, Inc.
Low
Report
Form 424B3 C4 Therapeutics, Inc.
11/15
04:06 pm
cccc
Form 424B5 C4 Therapeutics, Inc.
Low
Report
Form 424B5 C4 Therapeutics, Inc.
11/14
07:53 pm
cccc
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Medium
Report
Form SC 13G/A C4 Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: